The toxic effect of fluoroacetate has been proved to be due to the enzymic synthesis of fluorocitrate Peters, Wakelin, Buffa & Thomas, 1953) . The hypothesis was advanced that fluorocitrate leads to the accumulation of citrate in animal tissues as a result of the inhibition of aconitase (Lotspeich, Peters & Wilson, 1952) . , working with impure fluorocitrate and crude aconitase preparations, produced tentative evidence that the inhibition was competitive. In order to establish this point the experiments ofPeters & Wilson (1952) were repeated and extended using the highly purified, stable aconitase preparation of Morrison (1954) . A comparison was also made of the effects of the enzymically prepared and synthetic fluorocitrate upon the enzyme. The conclusion that the inhibition of aconitase by enzymically prepared fluorocitrate is competitive has been confirmed; at the same time interesting differences in the action of the two fluorocitrate preparations on aconitase have appeared. For a preliminary communication, see Morrison & Peters (1954) . EXPERIMENTAL Preparatim and activation of aconita8e. Aconitase was prepared and activated in the presence of 5 x 10-4M-Fe2+ and 1O-2M cysteine as described by Morrison (1954) . The enzyme solutions contained between 30 and 50,ug. of the final aconitase preparation/ml.
Formation of cis-aconitate. Aconitase activity was determined by following the formation of cis-aconitate from isocitrate at 240 mp. by the method of Racker (1950) .
It was found that when aconitase, activated with Fe2+ and cysteine, was added to both citrate and i8ocitrate there was a rapid initial increase in the extinction coefficient. With isocitrate as substrate, this rapid increase continued over a period of about 1 min., after which the reaction rate became linear. With citrate as substrate, the reaction rate became linear after about 2 min. This rapid increase in the extinction coefficient was a non-enzymic reaction, for when Fe2+ and cysteine were added to citrate or isocitrate in the same concentrations in which they were present in the enzyme solution, identical rapid increases in the extinction coefficient were obtained. At the point where the reaction rate in the presence of the enzyme became linear, the nonenzymic reaction ceased. In view of this finding, it was important to distinguish the non-enzymic from the enzymic reaction rate. Only the enzymic reaction rates have been plotted in the graphs.
Reagents. Fluorocitrate synthesized enzymically will be referred to as 'natural' fluorocitrate. Samples were prepared by the method of Peters, Wakelin, Buffa & Thomas (1953) . Specimens of synthetic fluorocitrate (Rivett, 1953) were given by Dr D. E. A. Rivett. Both preparations had been standardized on kidney particles by the method of Buffa, Peters & Wakelin (1951) .
Trichloromethyl paraconic acid was prepared by the method of Fittig & Miller (1889) and converted into DLi8ocitric lactone by the method of Krebs & Eggleston (1944) . Sodium isocitrate was formed by hydrolysis of the lactone with NaOH as described by Krebs & Eggleston (1944) . L-Cysteine hydrochloride was obtained from Roche Products Ltd. All other reagents were A.R.
RESULTS

Stabilization of aconitase during pre-incubation
in the presence of phosphate The rapid inactivation of aconitase by phosphate buffer in the absence of substrate has previously been reported by Morrison (1954) . As it was desired to repeat some of the experiments of , in which aconitase had been preincubated with fluorocitrate for 15 min. in the presence of phosphate, it was necessary to find a means of preventing or reducing the inactivation of the enzyme during a pre-incubation period. It was found that the addition of a crude heart-muscle extract, in which the aconitase activity had been destroyed by the addition of hydrochloric acid to pH 4, prevented the phosphate inactivation of the enzyme. However, this method had the disadvantage of introducing unknown components into the system. Aconitase could also be stabilized to an appreciable extent by the addition of small amounts of iwocitrate during the pre-incubation of the enzyme in the presence of phosphate. Fig. 1 shows the marked loss of enzyme activity that occurs during 15 min. pre-incubation with 0-05M phosphate buffer, pH 7-7, and that small increasing amounts of i8ocitrate reduce the loss ofactivity. In the presence of 0-5 umole of isocitrate/3 ml., about 70 % of the enzyme activity remained as compared with the activity of the non-incubated enzyme. This concentration of isocitrate was chosen for stabilizing aconitase when pre-incubation of the enzyme in the presence of phosphate buffer was carried out.
Studies with naturalfluorocitrate Several experiments were made with varying quantities of fluorocitrate. Fig. 2 illustrates the results of an experiment in which natural fluorocitrate (1-6 x 10-4M) was pre-incubated with aconitase in the presence of phosphate buffer and 0-5 panole of isocitrate; at the end of the incubation period, varying quantities of isocitrate were added at intervals and the rate of cis-aconitate formation determined.
Testfor the presence ofan irreversible inhibitor. The greater toxicity of natural fluorocitrate to the kidney-particle aconitase than to the isolated aconitase suggested the possibility that the fluorocitrate isolated from the kidney particles may not be the substance which is markedly toxic, but that it is converted into this substance when incubated with the kidney particles. Moreover, whereas the inhibition of the isolated aconitase by natural fluorocitrate is readily reversed, it is not yet known whether the inhibition in vivo is reversible; the attempts to reverse the in vivo inhibition have been unsuccessful (Hastings, In order to determine whether or not natural fluorocitrate was converted into an irreversible inhibitor, it was incubated with the kidney particles under the usual test conditions described by Buffa et al. (1951) . After acid-inactivation of the aconitase, the supernatant was tested for the presence of an irreversible inhibitor in the system, ci8-aconitate citrate. This system was used on account of the high absorption of the extract at 240 mM. which did not permit of the study of the reaction, isocitrate -+ c8-aconitate. No evidence was found for the presence of an irreversible inhibitor. This appears to exclude the possibility that fluorocitrate is converted into some other 'active' compound, but it must be pointed out that the technical difficulties were great because of the relatively large amounts of citrate which were present in the extract containing fluorocitrate. Citrate had to be added during the incubation so that the kidney particles did not become inactivated. After the addition of 20 ,umoles of i8ocitrate, the plot of the reaction rate of the sample containing the inhibitor became parallel with the plot of the control rate, thereby showing complete reversal of the inhibition and proving the competitive nature of the inhibitor. Fig. 3 Inhibition of aconita8e by fluorocitrate with preincubation. Fig. 4 shows that when aconitase is pre-incubated with fluorocitrate (2-4 x 10-5M) in the presence ofphosphate buffer and a small amount of i8ocitrate, marked inhibitions are obtained after the reaction is started by the addition of larger amounts of i8ocitrate. The inhibition is nearly 90 % when the reaction is started with 2,moles of 8O-citrate and about 80% when 16,umoles i8ocitrate are used. These results appeared to indicate that the inhibition was largely irreversible as it was nearly independent of the substrate concentration.
Because of the small amount of enzyme used in these tests (3-5 pg. protein/3 ml.), the molar ratio of fluorocitrate to enzyme must have been high. Therefore, it was possible that the fluorocitrate could be acting as a non-specific denaturing agent. As a check on this point, the above experiments were repeated in the presence of crystalline bovine serum albumin at a concentration 1000 times that of the enzyme. As the results were not altered by the presence of a large excess of inactive protein, the possibility that the inhibition was non-specific was rendered much less likely. The final aconitase preparation (5Mg.), activated by Fe2+ and cysteine, was incubated with fluorocitrate (2.4 x 10-5M) for 15 min. in the presence of 0-05M phosphate buffer, pH 7-7, and 0-5pmole of i8ocitrate. Substrate was then added and the reaction rates were determined as described in the text. Total volume 3-0 ml., temp. 220. x , reaction rate in the presence of 16 ,umoles of i8ocitrate alone (curve 1); with fluorocitrate (curve 3); *, reaction rate in the presence of 2 Mmoles of i8ocitrate alone (curve 2) and with fluorocitrate (curve 4).
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VoI. 58 incubation. It was found that the inhibition was dependent on the substrate concentration when the enzyme was not pre-incubated with fluorocitrate. Table 1 shows a comparison of the inhibitions obtained with and without pre-incubation. It can be seen that pre-incubation makes little difference to the inhibition when 2 jAmoles of i8ocitrate are added, but when 16 pmoles of i8ocitrate are added, there is an appreciable difference. These findings are not consistent with the idea that synthetic fluorocitrate is simply an irreversible inhibitor of aconitase.
A more detailed investigation was made of the effect of the substrate concentration on the inhibition of aconitase by fluorocitrate without pre- substrate concentration, a secondary reaction occurs between the enzyme and fluorocitrate so that the reversal of the inhibition is rendered more difficult.
As seen in Fig. 6 and or not the inhibition could be completely reversed. Fig. 7 shows that a further increase in the i8ocitrate concentration reduces the inhibition still further, but at this level of the inhibitor it was not practical to add larger amounts of substrate. It can be seen that the final reaction rate in the control tube decreased because of the dilution of the solution. When the concentration of fluorocitrate was reduced to one-quarter the concentration, that is to 0*6 x 10-5M, the inhibition could be completely reversed as shown in Fig. 8 . The initial inhibition in this case was small, being only 20 % as compared with 60 % with 2*4 x 10-5M fluorocitrate.
Inhibition of isocitric dehydrogena8e. It was found that there was no significant inhibition of 8ocitric dehydrogenase by synthetic fluorocitrate (2.4 x 10-5M) following pre-incubation ofthe enzyme with the inhibitor for 15 min.
DISCUSSION
It appears to be settled that the effect of fluorocitrate in causing the accumulation of citrate in animal tissues is due to its inhibitory effect on aconitase. It is also clear that the inhibitory action of the synthetic fluorocitrate is not only greater, but also differs in some respects from that obtained with the natural fluorocitrate. However, it must be pointed out that the relatively small amount of natural fluorocitrate which was available did not permit of extensive investigations at the higher levels of inhibition. A discussion of the possible reasons for this difference in toxicity will be deferred until the mode of action of each compound is discussed separately.
Natural fluorocitrate There was no evidence of complicating factors in the inhibition of aconitase by natural fluorocitrate. The inhibition is competitive and can be readily reversed by higher concentrations of substrate. One outstanding fact with this compound which is confirmed here, is its greater toxicity in vivo and in the kidney-particle test system of Buffa et al. (1951) as compared with its toxicity in the isolated aconitase system . The only explanation for this at present advanced is the suggestion of that the inhibitor is concentrated within the kidney particles or the mitochondria of cells so that the molar ratio of the inhibitor to enzyme is very much higher than that obtained with the soluble enzyme with the amounts of fluorocitrate used.
Synthetic fluorocitrate It is clear from the Lineweaver-Burk plot (Fig. 5) that synthetic fluorocitrate can act as a competitive inhibitor of aconitase, at least during the initial stages of the reaction. However, if the fluorocitrate were simply a competitive inhibitor of aconitase, pre-incubation of the enzyme and inhibitor should not increase the degree of inhibition. This, together with the fact that the reaction rates in the presence of the inhibitor fall after a time, even though the control rates are still linear, suggest that a slow irreversible type of inhibition is also taking place.
If the reaction rates could have been studied for longer periods, it is likely that this change of rate would have been emphasized. However, the reaction i8ocitrate -c68-aconitate could not be studied for long periods on account of the further conversion of ci8-aconitate into citrate, which complicates the measurement of c8-aconitate production. The latter results also seem to indicate that the time at which the irreversible type of inhibition manifests itself is a function of the substrate concentration. It appears as though the addition of substrate at low concentrations is equivalent to preincubation; prolonged pre-incubation of enzyme and inhibitor followed by the addition of substrate in low concentration is no more effective in increasing the degree of inhibition than the addition of a low substrate concentration alone. But preincubation does increase the inhibition when higher substrate concentrations are used.
It would seem as though the results can best be explained according to a combination of the following equations along usual lines:
E+S ES -E+P, (1) (2) where E = enzyme, S = substrate, I = inhibitor, ES= enzyme-substrate complex, P = reaction products, EI = enzyme-inhibitor complex, and EI' = secondary complex formed between the enzyme and inhibitor. First, there is competitive inhibition between the inhibitor and substrate for the active centre(s) of the enzyme; this equilibrium is set up rapidly. This is followed by a slower reaction on the enzyme surface such that the inhibitor acts either in an irreversible fashion, or in a way that makes displacement of it from the enzyme surface more difficult. It is this latter reaction that would occur during the period of pre-incubation of the enzyme with the inhibitor, or during the course of the reaction. Since the infrared data appear to exclude the presence of an appreciable amount of another compound in the synthetic substance, the differences in the action of the two fluorocitrate preparations on the isolated aconitase must be attributed to the presence of different stereoisomers in each preparation; from the mode of synthesis four stereoisomers should be present. On the other hand, it is unlikely that more than two stereoisomers would be formed enzymically. Peters, Wakelin, Rivett & Thomas (1953) found that there was a difference in the ability of natural and synthetic fluorocitrate to inhibit the disappearance of citrate in kidney particles; in this instance, however, the reverse occurred, the synthetic fluorocitrate being only half as active as the natural fluorocitrate. Admittedly, the results with the kidney particles are not exact, but on the basis that the four stereoisomers were present in equal amounts, these authors concluded that only one optically active centre was concerned in the inhibition. In the experiments with the isolated aconitase, the synthetic is far more active than the natural. It would seem as though the isomers present in the synthetic material, but not present in the natural fluorocitrate, are responsible for the different effects.
Possible explanations for the difference in the toxicity of synthetic fluorocitrate in the kidneyparticle test system as found by Peters, Wakelin, Rivett & Thomas (1953) and in the isolated aconitase system are difficult. It might be argued that the 'unnatural' stereoisomers do not penetrate the mitochondria or particles, but it is difficult to see why they should not do so. It might also be suggested that, consistent with the recent photographs of the organization within mitochondria (Palade, 1953; Claude, 1954) , the 'unnatural' stereoisomers cannot get at the aconitase owing to structural orientation. On the other hand, if all four stereoisomers are free to react with the aconitase but no reaction takes place, it must be postulated that there is some structural difference between the enzyme within the kidney particles and in the isolated state. Perhaps with the isolated enzyme, the 'unnatural' stereoisomers of synthetic fluorocitrate react with groups on the enzyme surface which are not exposed when the enzyme is fixed and surrounded by other enzyme molecules in the kidney particles. If this means that the enzyme behaves differently in the organized and unorganized condition, it raises a matter needing weighty consideration. More conclusive results must await the separation of the stereoisomers of synthetic fluorocitrate and the determination of which stereoisomer(s) is (or are) formed enzymically. SUMMARY 1. The competitive inhibition of aconitase by natural fluorocitrate has been established.
2. On the other hand, synthetic fluorocitrate has been shown to inhibit aconitase in both a competitive and an apparent irreversible fashion.
3. The dissociation constants of the aconitasefluorocitrate complexes for both the natural and synthetic fluorocitrates have been measured. The affinity of aconitase for the synthetic compound is much greater than for the natural compound.
4. The possible reasons have been discussed for the difference between the two preparations of fluorocitrate in inhibiting the isolated aconitase and also for the difference between the action of these compounds on the isolated aconitase system as compared to their action in vivo and on the kidney-particle system. 
